Cell-derived subunit influenza vaccine (3 lots)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cell-derived subunit influenza vaccine (3 lots), covering 2013-01-18 to 2013-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60) [Phase 3]